FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "QuVa Pharma, Inc.(036662848)" | Lidocaine Hydrochloride | 91 mg/10 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine Hydrochloride Anhydrous | 10 mg/100 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine Hydrochloride Anhydrous | 150 mg/30 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Lidocaine Hydrochloride; Hyoscyamine Sulfate | 300 mg/55 mL; .275 mg/55 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Neostigmine Methylsulfate | 3 mg/3 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Neostigmine Methylsulfate | 5 mg/5 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Neostigmine Methylsulfate | 3 g/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Neostigmine Methylsulfate | 3 g/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Neostigmine Methylsulfate | 5 mg/5 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 8 mg/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 4 mg/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 3 g/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Norepinephrine Bitartrate | 8 mg/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 30000 [USP'U]/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 8500 [USP'U]/850 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Oxytocin | 30 U/500 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine Hydrochloride | 1000 ug/10 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine Hydrochloride | 1000 ug/10 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine Hydrochloride | 4000 ug/10 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine Hydrochloride | 8000 ug/10 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine Hydrochloride | 300 mg/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Phenylephrine Hydrochloride | 300 mg/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Rocuronium Bromide | 50 mg/10 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Ropivacaine Hydrochloride | 6 g/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Sodium Bicarbonate | 50 meq/50 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine Chloride | 100 mg/10 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine Chloride | 100 mg/5 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine Chloride | 60 g/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine Chloride | 60 g/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine Chloride | 200 mg/10 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Succinylcholine Chloride | 200 mg/10 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.25 g/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1.5 g/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 375 g/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Vancomycin Hydrochloride | 1 g/250 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Droperidol | .625 g/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(036662848)" | Droperidol | 1875 mg/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(080064259)" | Aluminum Hydroxide; Magnesium Hydroxide; Lidocaine Hydrochloride; Diphenhydramine Hydrochloride; Dimethicone | 13.36 mg/1 mL; 13.36 mg/1 mL; 6.68 mg/1 mL; .835 mg/1 mL; 1.336 mg/1 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(080064259)" | Amiodarone Hydrochloride | 5400 mg/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(080064259)" | Glycopyrrolate | 600 mg/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(080064259)" | Heparin Sodium | 750 [USP'U]/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(080064259)" | Hydromorphone Hydrochloride | 600 mg/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(080064259)" | Hydromorphone Hydrochloride | 3 g/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(080064259)" | Hydromorphone Hydrochloride | 1.5 g/1500 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(080064259)" | Hydromorphone Hydrochloride | 1.5 g/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(080064259)" | Hydromorphone Hydrochloride | 3 g/1500 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ketamine Hydrochloride | 3 g/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ketamine Hydrochloride | 30 g/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(080064259)" | Ketamine Hydrochloride | 25 g/500 mL | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "QuVa Pharma, Inc.(080064259)" | Labetalol Hydrochloride | 15 g/3000 mL | 2019-1 | source_no_ndc | 2026-11-14 |